An example of an ADC is trastuzumab‐emtamsine (Kadcyla ®), a breakthrough formulation that targets the HER2 receptor and delivers emtasine to cancer cells in HER2‐positive metastatic breast cancer.45 This evidence concerns the gene ERBB2 and cancer.